Edwards recalls arterial cannulae due to risk of wire exposure that may cause serious patient harm.
Similar Posts
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
Sandoz, Inc. (“Sandoz”) is initiating a voluntary recall of one (1) lot of Cefazolin for Injection, USP, 1 gram per vial.July 18, 2025: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement – 07/18/2025
July 18, 2025: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting AnnouncementEndothelin Receptor Antagonist REMS Information
FDA has determined that a REMS is no longer necessary to ensure ERA medicines’ benefits outweigh the risk of EFT.Guangdong Renhe Guozhuang Biotechnology Co., Ltd. – 719045 – 12/16/2025
CGMP/Finished Pharmaceuticals/AdulteratedZapMax may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use ZapMax, a product promoted and sold for sexual enhancement on various websites, including www.amazon.com, and possibly in some retail stores.Biopreventative Company LLC dba Biopreventative – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet
